• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>ISRN Hypertension >The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
【24h】

The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era

机译：第三届加拿大丙型肝炎病毒研讨会：在无干扰素时代扩大护理

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Hepatitis C virus (HCV) currently infects approximately 250,000 individuals in Canada and causes more years of life lost than any other infectious disease in the country. In August 2011, new therapies were approved by Health Canada that have achieved higher response rates among those treated, but are poorly tolerated. By 2014/2015, short-course, well-tolerated treatments with cure rates >95% will be available. However, treatment uptake is poor due to structural, financial, geographical, cultural and social barriers. As such, ‘Barriers to access to HCV care in Canada’ is a crucial topic that must be addressed to decrease HCV disease burden and potentially eliminate HCV in Canada. Understanding how to better care for HCV-infected individuals requires integration across multiple disciplines including researchers, clinical services and policy makers to address the major populations affected by HCV including people who inject drugs, baby boomers, immigrants and Aboriginal and/or First Nations people. In 2012, the National CIHR Research Training Program in Hepatitis C organized the 1st Canadian Symposium on Hepatitis C Virus (CSHCV) in Montreal, Quebec. The 2nd CSHCV was held in 2013 in Victoria, British Columbia. Both symposia were highly successful, attracting leading international faculty with excellent attendance leading to dialogue and knowledge translation among attendees of diverse backgrounds. The current article summarizes the 3rd CSHCV, held February 2014, in Toronto, Ontario.
机译：丙型肝炎病毒（HCV）目前在加拿大感染约25万个人，比该国任何其他传染病造成更多的生命损失。 2011年8月，加拿大卫生部批准了新疗法，这些新疗法在接受治疗的患者中反应率较高，但耐受性差。到2014/2015年，将提供治愈率> 95％的短疗程，耐受性良好的治疗方法。但是，由于结构，财务，地理，文化和社会障碍，治疗的吸收较差。因此，“加拿大获得HCV护理的障碍”是至关重要的话题，必须降低加拿大的HCV疾病负担并潜在消除HCV。要了解如何更好地照顾受HCV感染的人，就需要跨多个学科进行整合，包括研究人员，临床服务人员和政策制定者，以解决受HCV影响的主要人群，包括注射毒品的人，婴儿潮一代，移民以及原住民和/或原住民。 2012年，美国国家CIHR丙型肝炎研究培训计划在魁北克蒙特利尔组织了第一届加拿大丙型肝炎病毒专题讨论会。第二届CSHCV于2013年在不列颠哥伦比亚省维多利亚举行。两次座谈会都非常成功，吸引了国际一流的教师参加，并吸引了来自不同背景的参与者进行对话和知识翻译。本文章总结了2014年2月在安大略省多伦多举行的第三届CSHCV。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号